Fresenius Medical Care (ETR:FME) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

Fresenius Medical Care AG (ETR:FME) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €38.19 ($39.37) and traded as high as €44.31 ($45.68). Fresenius Medical Care shares last traded at €44.16 ($45.53), with a volume of 149,457 shares trading hands.

Fresenius Medical Care Stock Down 1.4 %

The company has a market capitalization of $12.77 billion, a price-to-earnings ratio of 24.05, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The firm’s 50 day moving average price is €42.03 and its two-hundred day moving average price is €38.22. The company has a current ratio of 1.46, a quick ratio of 0.80 and a debt-to-equity ratio of 77.56.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.